Wisely Entrust Vaccine Design Projects to Creative Biolabs

 Breaking News
  • No posts were found

Wisely Entrust Vaccine Design Projects to Creative Biolabs

Empowered by the most up-to-date genetic engineering technologies, Creative Biolabs is fully competent to offer first-grade services regarding vaccine design to help develop highly immunogenic and safe vaccine candidates efficiently and cost-effectively.

New York, USA – August 7, 2020 – Since the outbreak of COVID-19, researchers from every corner of the world are working devotedly to find out effective vaccines targeting this highly infectious disease that is caused by a novel coronavirus, SARS-CoV-2. Creative Biolabs has been exploring the field of vaccine development for over a decade, which has accomplished hundreds of successful cases about vaccine design, formulation development, GMP manufacturing, and so on. Holding the expertise and rich experience, scientists at Creative Biolabs have the confidence to help design and develop an effective vaccine to turn the tables.

To facilitate customers as much as possible, the vaccine solution center of Creative Biolabs provides comprehensive services of vaccine design that comprise in silico vaccine design, vaccine target validation, and multiple antigen display technology.

In silico vaccine design: fundamental and the most crucial step that utilizes vaccine database and in silico vaccine design models, supported by computer-aided informatics and high-throughput techniques. The database plays a part in collecting information about the experimentally verified vaccine and vaccine components. By computational approaches, scientists can make a prediction of the component and structure of novel vaccines, which is meanwhile supported by in silico models to speed up the process, and predict the immune epitopes of T cell and B cell.

Specialized in biomarker discovery and data analysis, Creative Biolabs provides vaccine target validation services (including vaccine target discovery and verification) to help researchers find out the desirable vaccine antigens that present no homology with human proteins, have no transmembrane regions, and can not cross-react among other antigens. Using the high throughput next generation sequencing (NGS) technology, the scientific team has realized more efficient sequencing of DNA and RNA and achieved:

• Reversible terminator sequencing (Illumina)
• 454 Pyrosequencing
• Ion torrent semiconductor sequencing
• Sequencing by ligation (SOLiD)

The final step of vaccine design helps obtain efficient antigens. Scientists at Creative Biolabs have broken through the confinement and established multiple antigen display technology platform with integrated features to achieve more effective and efficient production.

After continuous exploration, Creative Biolabs has gradually established a series of integrated solutions, including but not limited to the scope of vaccine design, development, and validation. As a supplement, associate substances (antigens, antibodies, adjuvants) are also offered at reasonable prices to meet with different research targets.

Visit the official website to learn more information: https://www.creative-biolabs.com/vaccine.

About Creative Biolabs

With a history of over 10 years, Creative Biolabs is nowadays a leading figure in the field of biotechnology, providing solutions to global customers, especially to those pharmaceutical companies that work on their new vaccine projects. The service catalog covers the entire pipeline of vaccine development, starting from vaccine design to in vitro and in vivo preclinical assessment.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-619-7922
Country: United States
Website: https://www.creative-biolabs.com/vaccine